Current status of sublingual immunotherapy for allergic rhinitis in Japan
Japanese cedar pollen (JCP) and house dust mite (HDM) are two major allergens that cause allergic rhinitis (AR) in Japan and the prevalence of AR is increasing. Pharmacothearpy is a commonly used treatment, but the level of patient satisfaction is very low. Allergen immunotherapy (AIT) is the only t...
Main Authors: | Keisuke Masuyama, Tomokazu Matsuoka, Atsushi Kamijo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893018300546 |
Similar Items
-
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
by: Simonetta Masieri, et al.
Published: (2011-02-01) -
Treating allergic rhinitis by sublingual immunotherapy: a review
by: Cristoforo Incorvaia, et al.
Published: (2012-06-01) -
Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis
by: Živković Zorica, et al.
Published: (2016-01-01) -
Role of whole saliva in the efficacy of sublingual immunotherapy in seasonal allergic rhinitis
by: Takenori Haruna, et al.
Published: (2019-01-01) -
Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis
by: Yanqiu Chen, et al.